DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Health X Platform Limited — Board Meeting Intimation

NSE 1 hr ago·30 Jul 2026, 1:54 pm

Health X Platform

Health X Platform Limited has announced that its board will meet on August 7, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a standard corporate procedure where the board reviews the company's performance before the results are made public.

For investors, this meeting is a key event as it signals that the company is preparing to disclose its quarterly earnings. The outcome of this meeting will determine the timeline for releasing the financial data, which is critical for assessing the company's current operational health and future growth prospects.

Investors should watch for the official release of these results to understand the company's profitability and operational efficiency. Any significant deviation from market expectations could impact the stock's short-term performance.